← FDA DRUG APPROVALS

FDA ANDA · ANDA089895

CHLORZOXAZONE

Sponsor: BARR

APPLICATION
ANDA089895
TYPE
ANDA
ORIGINAL APPROVAL
1988-05-04
LATEST ACTION
1999-12-21
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

CHLORZOXAZONEDiscontinued
CHLORZOXAZONE 500MG · TABLET · ORAL

Approval history

1999-12-21Manufacturing (CMC) · Supplement 16AP
1999-09-07Manufacturing (CMC) · Supplement 14AP
1999-09-07Manufacturing (CMC) · Supplement 15AP
1999-05-20Manufacturing (CMC) · Supplement 13AP
1998-12-01Manufacturing (CMC) · Supplement 12AP
1998-07-06Manufacturing (CMC) · Supplement 11AP
1997-06-20Manufacturing (CMC) · Supplement 10AP
1996-02-05Labeling · Supplement 9AP
1994-12-23Manufacturing (CMC) · Supplement 8AP
1994-10-17Manufacturing (CMC) · Supplement 7AP
1994-10-11Manufacturing (CMC) · Supplement 6AP
1993-10-05Labeling · Supplement 5AP
1992-04-03Manufacturing (CMC) · Supplement 4AP
1992-04-03Manufacturing (CMC) · Supplement 2AP
1991-02-06Labeling · Supplement 1AP
1988-05-04OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →